Multiple endocrine neoplasia type 2 (MEN2) is an inherited cancer syndrome associated with germline variations of the RET proto-oncogene, which encodes a tyrosine kinase receptor whose activation promotes cell growth, proliferation, and differentiation. The gene discussed is NTRK1; the disease is multiple endocrine neoplasia type 2.